-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Buy on Boston Scientific, Lowers Price Target to $67

Benzinga·07/30/2026 20:25:47
语音播报
UBS analyst Patrick Wood maintains Boston Scientific (NYSE:BSX) with a Buy and lowers the price target from $74 to $67.